IMP
Process View
regulation of platelet activation
Any process that modulates the rate or frequency of platelet activation. Platelet activation is a series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of platelet activation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.812 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.750 | ||
| C1QA | complement component 1, q subcomponent, A chain | 0.690 | Human | |
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.646 | Human | |
| VEGFA | vascular endothelial growth factor A | 0.473 | Human | |
| PLCG1 | phospholipase C, gamma 1 | 0.395 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.221 | Human | |
| NRP1 | neuropilin 1 | 0.173 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.168 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.149 | ||
| SYK | spleen tyrosine kinase | 0.087 | Mouse | |
| C1QC | complement component 1, q subcomponent, C chain | 0.064 | Human | |
| PCYT2 | phosphate cytidylyltransferase 2, ethanolamine | 0.060 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.050 | ||
| EGFR | epidermal growth factor receptor | 0.049 | ||
| FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.046 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.041 | ||
| LAT | linker for activation of T cells | 0.038 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.035 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.029 | ||
| C1QB | complement component 1, q subcomponent, B chain | 0.028 | Human | |
| GAB1 | GRB2-associated binding protein 1 | 0.027 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.025 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.022 | Human | |
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.021 | ||
| PGF | placental growth factor | 0.019 | Human | |
| HP | haptoglobin | 0.018 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.017 | ||
| APOC1 | apolipoprotein C-I | 0.015 | ||
| LY96 | lymphocyte antigen 96 | 0.014 | ||
| LCAT | lecithin-cholesterol acyltransferase | 0.014 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.013 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.012 | ||
| BTK | Bruton agammaglobulinemia tyrosine kinase | 0.012 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.011 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.011 | ||
| ZNF746 | zinc finger protein 746 | 0.011 | ||
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | 0.010 | ||
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.010 | ||
| KITLG | KIT ligand | 0.010 |